Why the study?
Does catheter ablation reduce recurrence of atrial arrhythmias and hospitalizations in patients with paroxysmal AF compared with antiarrhythmic drugs?
Does catheter ablation reduce recurrence of atrial arrhythmias and hospitalizations in patients with paroxysmal AF compared with antiarrhythmic drugs?
As a first-line therapy for paroxysmal AF, catheter ablation reduces arrhythmia recurrence and hospitalizations without increasing major adverse events compared to antiarrhythmic drugs.
Supports first-line catheter ablation in paroxysmal AF; strengthens RCT evidence for fewer recurrences and hospitalizations.
In this meta-analysis of randomized clinical trials including first-line therapy of patients with paroxysmal AF, catheter ablation compared with antiarrhythmic drugs was associated with reductions in recurrence of atrial arrhythmias and hospitalizations, with no difference in major adverse events.
No takes yet. Share an insight, caveat, or question.
Turagam et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: